These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 13350341

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparative effects of insulin and orinase on blood levels of pyruvate and alpha-ketoglutarate in normal subjects.
    CONN JW, FAJANS SS, HENNES AR, WAJCHENBERG BL.
    Metabolism; 1957 Jan; 6(1):63-9. PubMed ID: 13386969
    [No Abstract] [Full Text] [Related]

  • 24. Clinical experience with U-2043 (orinase).
    CLARKE WT.
    Can Med Assoc J; 1956 Jun 15; 74(12):998. PubMed ID: 13329958
    [No Abstract] [Full Text] [Related]

  • 25. Clinical experience and experimental studies with tolbutamide.
    CRAIG JW, MILLER M.
    Diabetes; 1957 Jun 15; 6(1):77-9; discussion, 85-90. PubMed ID: 13397433
    [No Abstract] [Full Text] [Related]

  • 26. [Hypoglycemic action of sulfonamide compounds].
    BUTTURINI U.
    G Clin Med; 1956 Sep 15; 37(9):1217-48. PubMed ID: 13384740
    [No Abstract] [Full Text] [Related]

  • 27. Action of the hypoglycemic sulfonyl compounds in hypophysectomized, adrenalectomized and depancreatized animals.
    HOUSSAY BA, PENHOS JC.
    Metabolism; 1956 Nov 15; 5(6 Part 2):727-32. PubMed ID: 13378039
    [No Abstract] [Full Text] [Related]

  • 28. [Treatment of aged diabetics with hypoglycemic sulfonamides].
    DEMOL O, MAHAUX J.
    Acta Clin Belg; 1956 Nov 15; 11(3):275-98. PubMed ID: 13339058
    [No Abstract] [Full Text] [Related]

  • 29. Orinase: its mode of action and use in the treatment of diabetes mellitus.
    HENRY WL, THOMAS RF, ALEXIS CP, KIM JH, HALL AS.
    J Natl Med Assoc; 1957 May 15; 49(3):139-41. PubMed ID: 13429340
    [No Abstract] [Full Text] [Related]

  • 30. ORAL HYPOGLYCEMIC agents.
    Nutr Rev; 1956 Jul 15; 14(7):203-4. PubMed ID: 13335036
    [No Abstract] [Full Text] [Related]

  • 31. In vitro studies on the action of sulfonamide hypoglycemic agents.
    VAUGHAN M.
    Science; 1956 May 18; 123(3203):885-6. PubMed ID: 13324105
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tolbutamide in treatment of diabetes mellitus.
    BUTTERFIELD WJ, FRY IK, HARDWICK C, HOLLING HE.
    Br Med J; 1957 Aug 10; 2(5040):325-7. PubMed ID: 13446469
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tolbutamide in diabetes; some clinical and biochemical studies.
    CROWLEY MF, WOLFF FW, BLOOM A.
    Br Med J; 1957 Aug 10; 2(5040):327-31. PubMed ID: 13446470
    [No Abstract] [Full Text] [Related]

  • 36. [Morphological changes of the pancreatic islets and their relations to carbohydrate metabolism; with special reference to peroral antidiabetic drugs].
    CREUTZFELDT W.
    Wien Z Inn Med; 1956 Jun 10; 37(6):217-30. PubMed ID: 13353187
    [No Abstract] [Full Text] [Related]

  • 37. [New hypoglycemic substances].
    ACHELIS JD, HAACK E, HARDEBECK K.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956 Jun 10; 228(1-2):163-5. PubMed ID: 13334598
    [No Abstract] [Full Text] [Related]

  • 38. Effects of tolbutamide and carbutamide on thyroid function.
    BROWN J, SOLOMON DH.
    Metabolism; 1956 Nov 10; 5(6 Part 2):813-9. PubMed ID: 13378051
    [No Abstract] [Full Text] [Related]

  • 39. Clinical experience with orinase.
    DUBE AH, FULMER HS, LLOYD CW.
    Metabolism; 1956 Nov 10; 5(6 Part 2):940-6. PubMed ID: 13378063
    [No Abstract] [Full Text] [Related]

  • 40. Clinical experience with orinase.
    DOLGER H.
    Metabolism; 1956 Nov 10; 5(6 Part 2):947-52. PubMed ID: 13378064
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.